BEAM

BEAM R&D Expenses

$408.66MTTM · USD

Period ending:

BEAM FY R&D ExpensesUSD
BEAM FY R&D Expenses2017-12-31: $5.86M2018-12-31: $33.87M2019-12-31: $54.62M2020-12-31: $103.18M2021-12-31: $387.09M2022-12-31: $311.59M2023-12-31: $437.38M2024-12-31: $367.56M2025-12-31: $409.62M$437.38M$0.00
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BEAM r&d expenses history

Research and development spending. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Beam Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
409,618,000
367,561,000
437,381,000
311,594,000
387,087,000
103,179,000
54,619,000
33,873,000
5,859,000

Compare r&d expenses

All BEAM financial metrics · BEAM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.